All news from General Medicine

Pacrotinib: Best Treatment For Myelofibrosis

Pacritinib was significantly more effective than the best available therapy, including ruxolitinib, in reducing splenomegaly and trended toward a reduction in total symptom score in patients with myelofibrosis and thrombocytopenia.